CalciMedica is trading at $2.16, down -5.88%, after broader market weakness linked to hotter wholesale-inflation signals and renewed Federal Reserve rate concerns.
- The S&P 500 and Dow Jones are also lower.
- No fresh company-specific catalyst was identified for September 10, 2026.
- The latest identified announcement is CalciMedica’s September 15 H.C. Wainwright conference presentation, which does not directly explain the decline.